Showing results (1661-1670 of 1,951) with videos related to
Sort By:
Pageof 196
Current Atherosclerosis Reports|November 25, 2010
Lipid effects of endocrine medicationsDan V Mihailescu, Avni Vora, Theodore MazzoneCurrent Atherosclerosis Reports|November 25, 2010
Are cardiovascular benefits in statin lipid effects dependent on baseline lipid levels?Keith C FerdinandCurrent Atherosclerosis Reports|July 21, 2011
The incremental value of lipids and inflammatory biomarkers in determining residual cardiovascular riskSandeep S Mangalmurti, Michael H DavidsonCurrent Atherosclerosis Reports|November 16, 2007
Rimonabant: the role of endocannabinoid type 1 receptor antagonism in modulating the weight and lipid profile of obese patientsChristopher T Dibble, Eli V Gelfand, Christopher P CannonCurrent Atherosclerosis Reports|November 16, 2007
Dyslipidemia in South Asian patientsEnas A Enas, Vinod Chacko, Suraj George Pazhoor, et al.Current Atherosclerosis Reports|November 16, 2007
Statin myopathy: incidence, risk factors, and pathophysiologyKimberly A Sewright, Priscilla M Clarkson, Paul D ThompsonCurrent Atherosclerosis Reports|November 30, 2011
Role of C-reactive protein when prescribing a statinScott KinlayCurrent Atherosclerosis Reports|April 28, 2012
International epidemiology of intracerebral hemorrhageM Arfan Ikram, Renske G Wieberdink, Peter J KoudstaalCurrent Atherosclerosis Reports|November 25, 2011
Advances in medical therapy for weight loss and the weight-centric management of type 2 diabetes mellitusLeon I Igel, Amanda G Powell, Caroline M Apovian, et al.Current Atherosclerosis Reports|January 18, 2012
Coronary heart disease in young adultsJessica B Rubin, William B BordenPageof 196